Neola Medical AB (publ) (STO:NEOLA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.880
0.00 (0.00%)
Mar 5, 2026, 4:26 PM CET
-61.40%
Market Cap 68.60M
Revenue (ttm) 8.28M
Net Income (ttm) -11.02M
Shares Out 77.95M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 61,583
Average Volume 40,262
Open 0.862
Previous Close 0.880
Day's Range 0.862 - 0.880
52-Week Range 0.602 - 3.040
Beta 1.22
RSI 50.15
Earnings Date Feb 12, 2026

About Neola Medical AB

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2016
Employees 8
Stock Exchange Nasdaq Stockholm
Ticker Symbol NEOLA
Full Company Profile

Financial Performance

In 2025, Neola Medical AB's revenue was 8.28 million, a decrease of -18.13% compared to the previous year's 10.12 million. Losses were -11.02 million, 9.52% more than in 2024.

Financial Statements

News

There is no news available yet.